title: Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans.
abstract: OBJECTIVE
  In animal models, the adipocyte-secreted hormone leptin increases energy expenditure by increasing sympathetic outflow but its role in humans remains to be elucidated. We evaluated whether inducing hypoleptinaemia (with and without administration of leptin at replacement doses) for 3 days would influence catecholamine levels and sympathetic and parasympathetic activity in healthy humans.
  
  
  METHODS
  We studied six normal-weight subjects in the General Clinical Research Center (GCRC) under three conditions: baseline fed state (control study) and two 72-h fasting studies (to decrease leptin levels), with administration of either placebo or replacement-dose recombinant methionyl human leptin (r-metHuLeptin) in a randomized, double-blind fashion. In each condition, 24-h urinary catecholamine levels, heart rate and heart rate variability (HRV), a standard tool for assessing cardiac autonomic modulation, were measured.
  
  
  RESULTS
  Study parameters remained stable during the control condition and the baseline assessment of all three studies. In response to 72-h fasting, which decreased serum leptin levels by 80%, 24-h urinary norepinephrine and dopamine levels and heart rate increased while cardiac vagal modulation decreased (all P < 0.05). Replacement-dose r-metHuLeptin to keep leptin levels within the physiological range during fasting did not alter fasting-associated changes in heart rate, catecholamine levels or cardiac vagal tone.
  
  
  CONCLUSIONS
  The findings of this controlled, interventional study indicate that changes in heart rate, catecholamine levels and cardiac vagal modulation associated with 72-h fasting are independent of regulation by leptin. Thus, changes in leptin levels within the physiological range do not seem to play a role in regulating autonomic function during short-term starvation in healthy humans.
authors.affiliation: Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
authors.forename: Jean L
authors.initials: JL
authors.lastname: Chan
authors.forename: Joseph E
authors.initials: JE
authors.lastname: Mietus
authors.forename: Patricia M
authors.initials: PM
authors.lastname: Raciti
authors.forename: Ary L
authors.initials: AL
authors.lastname: Goldberger
authors.forename: Christos S
authors.initials: CS
authors.lastname: Mantzoros
mesh_terms: D000328:Adult; D001341:Autonomic Nervous System / Q000502:physiology*; D002395:Catecholamines / Q000097:blood*; D003404:Creatinine / Q000652:urine; D004298:Dopamine / Q000652:urine; D004311:Double-Blind Method; D004837:Epinephrine / Q000652:urine; D005215:Fasting; D005260:Female; D006339:Heart Rate; D006801:Humans; D020738:Leptin / Q000097:blood*; D009638:Norepinephrine / Q000652:urine; D012815:Signal Processing, Computer-Assisted; D012964:Sodium / Q000652:urine; D018709:Statistics, Nonparametric
chemical_list: D002395:Catecholamines; D020738:Leptin; D012964:Sodium; D003404:Creatinine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine